MannKind Corporation to Present at The Piper Jaffray 25th Annual Healthcare Conference Piper Jaffray Healthcare Conference 2013 Business Wire VALENCIA, Calif. -- November 27, 2013 MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing and commercializing treatments for diabetes, announced today that it will present at The Piper Jaffray 25th Annual Healthcare Conference on Wednesday, December 4, 2013 at 10:00 AM (ET) at The New York Palace, New York, New York. Interested parties can access a link to the live webcast of the presentations from the News & Events section of the Company's website at http://www.mannkindcorp.com. About MannKind Corporation MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes. Its lead product candidate, AFREZZA®, has completed Phase 3 clinical trials. MannKind maintains a website at www.mannkindcorp.com to which MannKind regularly posts copies of its press releases as well as additional information about MannKind. Interested persons can subscribe on the MannKind website to e-mail alerts that are sent automatically when MannKind issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website. Contact: MannKind Corporation Matthew Pfeffer Chief Financial Officer 661-775-5300 email@example.com
MannKind Corporation to Present at The Piper Jaffray 25th Annual Healthcare Conference
Press spacebar to pause and continue. Press esc to stop.